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Transcriptional dysregulation is the hallmark of HTLV-1
infected cells yet the impact of HTLV-1 on alternative
splicing (AS) remains unknown. Given that about 95%
of genes are spliced, we investigated the exon expression
profiling of CD4+ T-cell clones obtained by limited-
dilution cloning of PBMC deriving from HTLV-1 car-
riers. Overall, 12 infected clones clustering in infected,
uninfected, PHA-stimulated or unstimulated CD4+ T
cells were compared for exon RNA content using Exon
Chip Human microarray. The splicing index method
was used to identify differentially expressed exons in
paired comparisons. The exon content of 558 genes dif-
fered between infected and uninfected CD4+ T cells. Of
these, only 76 genes were found differentially expressed
at the whole transcriptional level. 360 exon events (185/
558 genes) could be manually annotated in FASTDB
database and corresponded to exon skipping (59 genes),
mutually exclusive exons (151), 5’ splice site (5’SS) (4),
3’SS (3), internal exon deletion (23), and intron reten-
tion (15). Some of these are already validated by exon
specific RT-PCR experiments that are in progress. Exon-
based hierarchical clustering analysis identified alterna-
tive exons associated with HTLV-1 infection and/or
PHA stimulation. Ingenuity Pathway Analysis revealed
new AS-based pathways of gene deregulation irrespec-
tive of whole transcriptional deregulation. These corre-
sponded to hitherto unknown deregulation pattern of
cell cycling and DNA damage response. Thus, HTLV-1
infection possesses a transcription-independent but AS-
based signature that unmasks numerous new putative
leukemogenic pathways.
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